# 0409-4282-01 · Lidocaine Hydrochloride Injection · Hospira, Inc., a Pfizer Company — FDA drug shortage duration tracker

For 0409-4282-01 · Lidocaine Hydrochloride Injection · Hospira, Inc., a Pfizer Company, package ndc is 0409-4282-01; generic name is Lidocaine Hydrochloride Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Available, recorded from its source on 2026-09-01; source re-checked 2026-09-11.

- **Package NDC:** 0409-4282-01 _(verified: appears in the quote below)_
- **Generic name:** Lidocaine Hydrochloride Injection _(verified: appears in the quote below)_
- **Manufacturer:** Hospira, Inc., a Pfizer Company _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 02/22/2012 _(verified: appears in the quote below)_
- **Last update date:** 08/24/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 5305 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Anesthesia _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "02/22/2012", "package_ndc": "0409-4282-01", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "844-646-4398", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current"

### Status

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current"

### Last update date

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current"

### Dosage form

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current"

### Therapeutic category

> "update_date": "08/24/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-11. Review by: 2026-09-14.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).